Human protein S inhibits the uptake of AcLDL and expression of SR-A through Mer receptor tyrosine kinase in human macrophages

Blood

Volumn 113, Issue 1, 2009, Pages 165-174

  Liao, Dan ^a   Wang, Xinwen ^a,b   Li, Min ^a   Lin, Peter H ^a,b   Yao, Qizhi ^a,b   Chen, Changyi ^a,b,c  

^a Division of Vascular Surgery and Endovascular Therapy   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; CHOLESTEROL ESTER; MER RECEPTOR TYROSINE KINASE; MESSENGER RNA; PROTEIN S; PROTEIN TYROSINE KINASE; SCAVENGER RECEPTOR A; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; ACETYL-LDL; AXL RECEPTOR TYROSINE KINASE; LOW DENSITY LIPOPROTEIN; MERTK PROTEIN, HUMAN; MSR1 PROTEIN, HUMAN; ONCOPROTEIN; TYRO3 PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; CELL LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; ATHEROSCLEROSIS; CELL STRAIN U937; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; METABOLISM;

ATHEROSCLEROSIS; CHOLESTEROL ESTERS; DOWN-REGULATION; GENE EXPRESSION; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; ONCOGENE PROTEINS; PROTEIN BINDING; PROTEIN S; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SCAVENGER RECEPTORS, CLASS A; TRANSCRIPTION, GENETIC; U937 CELLS;

EID: 59449100401     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-05-158048     Document Type: Article

References (35)

1. Esmon CT. Regulation of blood coagulation. Biochim Biophys Acta. 2000;1477:349-360.
2. Dahlbäck B. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system. Thromb Haemost. 1991;66:49-61.
3. Pegelow CH, Ledford M, Young JN, Zilleruelo G. Severe protein S deficiency in a newborn. Pediatrics. 1992;89:674-676.
4. Gladson CL, Scharrer I, Hach V, Beck KH, Griffin JH. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost. 1988;59:18-22.
5. Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood. 1984;64:1297-1300.
6. Green D, Otoya J, Oriba H, Rovner R. Protein S deficiency in middle-aged women with stroke. Neurology. 1992;42:1029-1033.
7. Prats JM, Garaizar C, Zuazo E, Lopez J, Pinan MA, Aragües P. Superior sagittal sinus thrombosis in a child with protein S deficiency. Neurology. 1992;42:2303-2305.
8. Beattie S, Norton M, Doll D. Coronary thrombosis associated with inherited protein S deficiency: a case report. Heart Lung. 1997;26:76-79.
9. Perez-Mijares R, Payan-Lopez J, Guzman-Zamudio JL, et al. Free protein S deficiency in hemodialysis patients due to vascular calcifications? Nephron. 1996;74:356-360.
10. Liu D, Guo H, Griffin JH, Fernandez JA, Zlokovic BV. Protein S confers neuronal protection during ischemic/hypoxic injury in mice. Circulation. 2003;107:1791-1796.
11. Dart AM, Cooper B, Kay SB, Salem H. Relationships between protein C, protein S, von Willebrand factor and euglobulin lysis time and cardiovascular risk factors in subjects with and without coronary heart disease. Atherosclerosis. 1998; 140:55-64.
12. Rudnicka AR, Miller GJ, Nelson T, Doray D, Comp PC. An association between plasma free protein s concentration and risk of coronary heart disease in middle-aged men. Thromb Res. 2001; 101:1-11.
13. Zhou L, Xu N, Nilsson A. Association of prothrombin and protein S with plasma triglyceride-rich lipoproteins in humans after test meals rich in milk fat or soybean oil. Thromb Res. 2002;108: 209-213.
14. Oksjoki R, Kovanen PT, Mayranpaa MI, et al. Complement regulation in human atherosclerotic coronary lesions: immunohistochemical evidence that C4b-binding protein negatively regulates the classical complement pathway, and that C5b-9 is formed via the alternative complement pathway. Atherosclerosis. 2007;192:40-48.
15. Godowski PJ, Mark MR, Chen J, Sadick MD, Raab H, Hammonds RG. Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3. Cell. 1995;82: 355-358.
16. Stitt TN, Conn G, Gore M, et al. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell. 1995;80:661-670.
17. Anderson HA, Maylock CA, Williams JA, Paweletz CP, Shu H, Shacter E. Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol. 2003;4:87-91.
18. Gasic GP, Arenas CP, Gasic TB, Gasic GJ. Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci U S A. 1992;89:2317-2320.
19. Greaves DR, Gordon S. Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors. J Lipid Res. 2005;46:11-20.
20. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
21. Ravandi A, Kuksis A, Shaikh NA. Glycated phosphatidylethanolamine promotes macrophage uptake of low density lipoprotein and accumulation of cholesteryl esters and triacylglycerols. J Biol Chem. 1999;274:16494-16500.
22. Massachusetts General Hospital. Primer Bank. http://pga.mgh.harvard.edu/ primerbank. Accessed November 20, 2006.
23. Moulton KS, Wu H, Barnett J, Parthasarathy S, Glass CK. Regulated expression of the human acetylated low density lipoprotein receptor gene and isolation of promoter sequences. Proc Natl Acad Sci U S A. 1992;89:8102-8106.
24. Moulton KS, Semple K, Wu H, Glass CK. Cellspecific expression of the macrophage scavenger receptor gene is dependent on PU. 1 and a composite AP-1/ets motif. Mol Cell Biol. 1994;14: 4408-4418.
25. Xu N, Dahlback B, Ohlin AK, Nilsson A. Association of vitamin K-dependent coagulation proteins and C4b binding protein with triglyceride-rich lipoproteins of human plasma. Arterioscler Thromb Vasc Biol. 1998;18:33-39.
26. Benzakour O, Kanthou C. The anticoagulant factor, protein S, is produced by cultured human vascular smooth muscle cells and its expression is up-regulated by thrombin. Blood. 2000;95:2008-2014.
27. Matsumoto A, Naito M, Itakura H, et al. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci U S A. 1990;87: 9133-9137.
28. Moore KJ, Freeman MW. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol. 2006;26:1702-1711.
29. Thorp E, Cui D, Schrijvers DM, Kuriakose G, Tabas I. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice. Arterioscler Thromb Vasc Biol. 2008;28:1421-1428.
30. Ait-Oufella H, Pouresmail V, Simon T, et al. Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis. Arterioscler Thromb Vasc Biol. 2008;28:1429-1431.
31. Murao K, Imachi H, Sayo Y, et al. A product of growth arrest-specific gene 6 modulates scavenger receptor expression in human vascular smooth muscle cells. FEBS Lett. 1999;459:363-366.
32. Ming Cao W, Murao K, Imachi H, et al. Phosphatidylinositol 3-OH kinase-Akt/protein kinase B pathway mediates Gas6 induction of scavenger receptor a in immortalized human vascular smooth muscle cell line. Arterioscler Thromb Vasc Biol. 2001;21:1592-1597.
33. Li H, Freeman MW, Libby P. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest. 1995;95:122-133.
34. Balogh I, Hafizi S, Stenhoff J, Hansson K, Dahlback B. Analysis of Gas6 in human platelets and plasma. Arterioscler Thromb Vasc Biol. 2005; 25:1280-1286.
35. Luttun A, Carmeliet P. Genetic studies on the role of proteinases and growth factors in atherosclerosis and aneurysm formation. Ann NY Acad Sci. 2001;947:124-132.